SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

Beam Therapeutics Q1 EPS $(3.35) Down From $(1.03) YoY

Beam Therapeutics (NASDAQ:BEAM) reported quarterly losses of $(3.35) per share. This is a 225.24 percent decrease over losses of $(1.03) per share from the same period last year.

05/11/2021 06:35
Beam Therapeutics (NASDAQ:BEAM) reported quarterly losses of $(3.35) per share. This is a 225.24 percent decrease over losses of $(1.03) per share from the same period last year.